Total Payments
$485.12
2024 Payments
$161.43
Companies
8
Transactions
25
Medicare Patients
3,225
Medicare Billing
$217,562
Payment Breakdown by Category
Food & Beverage$485.12 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $485.12 | 25 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $164.66 | 9 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $100.15 | 4 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $91.01 | 6 | $0 (2022) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $37.18 | 2 | $0 (2024) |
| GENZYME CORPORATION | $28.53 | 1 | $0 (2024) |
| Lilly USA, LLC | $27.58 | 1 | $0 (2024) |
| PFIZER INC. | $20.50 | 1 | $0 (2023) |
| Galderma Laboratories, L.P. | $15.51 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $161.43 | 7 | ABBVIE INC. ($60.08) |
| 2023 | $60.91 | 2 | Regeneron Healthcare Solutions, Inc. ($40.41) |
| 2022 | $176.25 | 11 | ABBVIE INC. ($66.61) |
| 2021 | $52.92 | 3 | Novartis Pharmaceuticals Corporation ($33.61) |
| 2020 | $18.66 | 1 | AbbVie Inc. ($18.66) |
| 2019 | $14.95 | 1 | Sun Pharmaceutical Industries Inc. ($14.95) |
All Payment Transactions
25 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.53 | General |
| Category: Immunology | ||||||
| 11/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: IMMUNOLOGY | ||||||
| 08/29/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT, ZEPBOUND | Food and Beverage | In-kind items and services | $27.58 | General |
| Category: Immunology | ||||||
| 06/19/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: Dermatology | ||||||
| 03/20/2024 | ABBVIE INC. | HUMIRA (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $26.97 | General |
| Category: IMMUNOLOGY | ||||||
| 01/19/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/01/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $40.41 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/20/2023 | PFIZER INC. | EUCRISA (Drug), CIBINQO | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: DERMATOLOGY | ||||||
| 12/08/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $12.22 | General |
| Category: IMMUNOLOGY | ||||||
| 10/20/2022 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: IMMUNOLOGY | ||||||
| 10/12/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: IMMUNOLOGY | ||||||
| 08/16/2022 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: IMMUNOLOGY | ||||||
| 07/20/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: IMMUNOLOGY | ||||||
| 07/13/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/02/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: IMMUNOLOGY | ||||||
| 06/02/2022 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: IMMUNOLOGY | ||||||
| 04/13/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 02/15/2022 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $12.15 | General |
| Category: IMMUNOLOGY | ||||||
| 01/04/2022 | Galderma Laboratories, L.P. | AKLIEF (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: ACNE | ||||||
| 10/19/2021 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $11.91 | General |
| Category: IMMUNOLOGY | ||||||
| 09/14/2021 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: IMMUNOLOGY | ||||||
| 04/15/2021 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: IMMUNOLOGY | ||||||
| 02/27/2020 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: IMMUNOLOGY | ||||||
| 08/20/2019 | Sun Pharmaceutical Industries Inc. | ILUMYA (Biological) | Food and Beverage | Cash or cash equivalent | $14.95 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 835 | 1,594 | $217,573 | $51,947 |
| 2022 | 9 | 678 | 1,284 | $174,676 | $45,659 |
| 2021 | 11 | 886 | 1,654 | $234,112 | $65,434 |
| 2020 | 10 | 826 | 1,514 | $155,526 | $54,522 |
Total Patients
3,225
Total Services
6,046
Medicare Billing
$217,562
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 158 | 201 | $46,230 | $11,115 | 24.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 74 | 118 | $38,940 | $9,247 | 23.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 85 | 105 | $30,501 | $8,144 | 26.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 167 | 223 | $37,544 | $7,543 | 20.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 106 | 114 | $30,331 | $6,639 | 21.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 135 | 717 | $11,881 | $3,612 | 30.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 35 | 35 | $9,975 | $2,653 | 26.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 37 | 38 | $5,510 | $1,439 | 26.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 21 | 26 | $3,515 | $1,058 | 30.1% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 17 | 17 | $3,145 | $496.72 | 15.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 148 | 192 | $44,160 | $11,635 | 26.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 98 | 112 | $29,799 | $8,052 | 27.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 72 | 78 | $22,658 | $6,473 | 28.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 41 | 68 | $22,440 | $6,009 | 26.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 127 | 165 | $27,779 | $5,824 | 21.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 104 | 572 | $9,478 | $2,900 | 30.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 33 | 33 | $9,405 | $2,264 | 24.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 27 | 33 | $4,462 | $1,372 | 30.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 28 | 31 | $4,495 | $1,130 | 25.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 202 | 276 | $59,645 | $16,958 | 28.4% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 136 | 146 | $37,727 | $10,671 | 28.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 49 | 86 | $26,437 | $7,780 | 29.4% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 57 | 93 | $25,530 | $7,717 | 30.2% |
| 17000 | Destruction of skin growth | Office | 2021 | 155 | 205 | $33,425 | $7,506 | 22.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 59 | 59 | $16,429 | $4,254 | 25.9% |
About Dr. Laura Morrison, MD
Dr. Laura Morrison, MD is a Diagnostic Radiology healthcare provider based in Seattle, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/02/2007. The National Provider Identifier (NPI) number assigned to this provider is 1003003153.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Laura Morrison, MD has received a total of $485.12 in payments from pharmaceutical and medical device companies, with $161.43 received in 2024. These payments were reported across 25 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($485.12).
As a Medicare-enrolled provider, Morrison has provided services to 3,225 Medicare beneficiaries, totaling 6,046 services with total Medicare billing of $217,562. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Diagnostic Radiology
- Other Specialties Dermatology
- Location Seattle, WA
- Active Since 10/02/2007
- Last Updated 06/01/2018
- Taxonomy Code 2085R0202X
- Entity Type Individual
- NPI Number 1003003153
Products in Payments
- SKYRIZI (Biological) $137.69
- DUPIXENT (Biological) $128.68
- COSENTYX (Biological) $91.01
- ILUMYA (Biological) $37.18
- TALTZ (Drug) $27.58
- HUMIRA (Biological) $26.97
- EUCRISA (Drug) $20.50
- AKLIEF (Drug) $15.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Diagnostic Radiology Doctors in Seattle
Guy Johnson
Diagnostic Radiology — Payments: $194,038
Diagnostic Radiology $194,038
Dr. Dushyant Sahani, Md, MD
Diagnostic Radiology — Payments: $152,032
Diagnostic Radiology $152,032
Eniola Oluyemi, Md, MD
Diagnostic Radiology — Payments: $146,823
Diagnostic Radiology $146,823
Marissa Lawson, Md, MD
Diagnostic Radiology — Payments: $141,917
Diagnostic Radiology $141,917
Nathan Cross, Md, MD
Diagnostic Radiology — Payments: $141,035
Diagnostic Radiology $141,035
Dr. Kathryn Lowry, M.d, M.D
Diagnostic Radiology — Payments: $80,445
Diagnostic Radiology $80,445